STAYING AHEAD BY STAYING INVESTED IN THE HEALTH OF CANADIANS.
As one of Canada’s leading research-based pharmaceutical companies, GlaxoSmithKline understands that scientists require commitment and resources to discover the next medical breakthrough. This is why we invested more than $141 million in Canadian research and development in 2010 alone. At GSK, we stay ahead by putting the health of Canadians before anything else. Discover more at GSK.ca
Corporate Profiles 2012.indd 2
2/7/12 2:06:12 PM